Mucocutaneous alterations and complications in amphetamine abusers: a narrative review

References

• Cao D-N, Shi J-J, Hao W, et al. Advances and challenges in pharmacotherapeutics for amphetamine-type stimulants addiction. Eur J Pharmacol. 2016;780:129–135. doi: 10.1016/j.ejphar.2016.03.040.
   PubMed Web of Science ®Google Scholar
• United Nations Office on Drugs and Crime. World Drug Report 2021, booklet 4, drug market trends: cocaine, amphetamine-type stimulants. Vol. 4. Austria: United Nations Publication; 2021.
   Google Scholar
• Courtney KE, Ray LA. Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature. Drug Alcohol Depend. 2014;143:11–21. doi: 10.1016/j.drugalcdep.2014.08.003.
   PubMed Web of Science ®Google Scholar
• Moshiri M, Roohbakhsh A, Talebi M, et al. Role of natural products in mitigation of toxic effects of methamphetamine: a review of in vitro and in vivo studies. Avicenna J Phytomed. 2020;10(4):334–351.
   PubMed Web of Science ®Google Scholar
• Moshiri M, Hosseiniyan SM, Moallem SA, et al. The effects of vitamin B12 on the brain damages caused by methamphetamine in mice. Iran J Basic Med Sci. 2018;21(4):434–438.
   PubMed Web of Science ®Google Scholar
• Noschang C, Lampert C, Krolow R, et al. Social isolation at adolescence: a systematic review on behaviour related to cocaine, amphetamine and nicotine use in rats and mice. Psychopharmacology. 2021;238(4):927–947. doi: 10.1007/s00213-021-05777-z.
   PubMed Web of Science ®Google Scholar
• Cruickshank CC, Dyer KR. A review of the clinical pharmacology of methamphetamine. Addiction. 2009;104(7):1085–1099. doi: 10.1111/j.1360-0443.2009.02564.x.
   PubMed Web of Science ®Google Scholar
• Harris DS, Boxenbaum H, Everhart ET, et al. The bioavailability of intranasal and smoked methamphetamine. Clin Pharmacol Ther. 2003;74(5):475–486. doi: 10.1016/j.clpt.2003.08.002.
   PubMed Web of Science ®Google Scholar
• Barnes AJ, Smith ML, Kacinko SL, et al. Excretion of methamphetamine and amphetamine in human sweat following controlled oral methamphetamine administration. Clin Chem. 2008;54(1):172–180. doi: 10.1373/clinchem.2007.092304.
   PubMed Web of Science ®Google Scholar
• Wright J, Symons B, Angell J, et al. Current practices underestimate environmental exposures to methamphetamine: inhalation exposures are important. J Expo Sci Environ Epidemiol. 2021;31(1):45–52. doi: 10.1038/s41370-020-00260-x.
   PubMed Web of Science ®Google Scholar
• Salocks CB, Hui X, Lamel S, et al. Dermal exposure to methamphetamine hydrochloride contaminated residential surfaces. II. Skin surface contact and dermal transfer relationship. Food Chem Toxicol. 2014;66:1–6. doi: 10.1016/j.fct.2013.12.044.
   PubMed Web of Science ®Google Scholar
• Parker K. Methamphetamine absorption by skin oils: accumulated mass, partition coefficients and the influence of fatty acids. Missouri University of Science and Technology; 2014. Available from: https://scholarsmine.mst.edu/masters_theses/7311
   Google Scholar
• Morrison G, Shakila NV, Parker K. Accumulation of gas-phase methamphetamine on clothing, toy fabrics, and skin oil. Indoor Air. 2015;25(4):405–414. doi: 10.1111/ina.12159.
   PubMed Web of Science ®Google Scholar
• Hartvig P. Skin absorption of dexamphetamine base – a case report. Eur J Clin Pharmacol. 1998;54(9–10):805–807. doi: 10.1007/s002280050555.
   PubMed Web of Science ®Google Scholar
• Stefaniak AB, Harvey CJ, Wertz PW. Formulation and stability of a novel artificial sebum under conditions of storage and use. Int J Cosmet Sci. 2010;32(5):347–355. doi: 10.1111/j.1468-2494.2010.00561.x.
   PubMedGoogle Scholar
• Garza-Esparza G, Alfaro-Sánchez AB, Welsh-Hernández EC. Manifestaciones cutáneas secundarias al consumo de estupefacientes. Dermatol Rev Mex. 2020;64(2):154–164.
   Google Scholar
• Selvaggi G, Spagnolo AG, Elander A. A review of illicit psychoactive drug use in elective surgery patients: detection, effects, and policy. Int J Surg. 2017;48:160–165. doi: 10.1016/j.ijsu.2017.10.074.
   PubMed Web of Science ®Google Scholar
• Liu SW, Lien MH, Fenske NA. The effects of alcohol and drug abuse on the skin. Clin Dermatol. 2010;28(4):391–399. doi: 10.1016/j.clindermatol.2010.03.024.
   PubMed Web of Science ®Google Scholar
• Albattal RRH, Ye-Li Y, Albloushi FAJ, et al. Dermatologic manifestations of substance abuse. Int J Sci Invent Today. 2021;10(2):131–152.
   Google Scholar
• Barco D, Gimenez-Arnau A. Xerosis: a dysfunction of the epidermal barrier. Actas Dermosifiliogr. 2008;99(9):671–682. doi: 10.1016/S1578-2190(08)70343-3.
   PubMedGoogle Scholar
• Lipman ZM, Yosipovitch G. Substance use disorders and chronic itch. J Am Acad Dermatol. 2021;84(1):148–155. doi: 10.1016/j.jaad.2020.08.117.
   PubMed Web of Science ®Google Scholar
• Hennings C, Miller J. Illicit drugs: what dermatologists need to know. J Am Acad Dermatol. 2013;69(1):135–142. doi: 10.1016/j.jaad.2012.12.968.
   PubMed Web of Science ®Google Scholar
• Bowman JD, Kim H, Bustamante JJ. Drug‐induced gynecomastia. Pharmacotherapy. 2012;32(12):1123–1140. doi: 10.1002/phar.1138.
   PubMed Web of Science ®Google Scholar
• Bergstrom KG. Cutaneous clues to drug addiction. J Drugs Dermatol. 2008;7(3):303–305.
   PubMed Web of Science ®Google Scholar
• Fisher AH, Stanciu CN. Amphetamine-induced delusional infestation. Am J Psychiatry Residents’ J. 2017;12(12):12–13. doi: 10.1176/appi.ajp-rj.2017.121204.
   Google Scholar
• Freudenmann RW, Kölle M, Schönfeldt-Lecuona C, et al. Delusional parasitosis and the matchbox sign revisited: the international perspective. Acta Derm Venereol. 2010;90(5):517–519. doi: 10.2340/00015555-0909.
   PubMed Web of Science ®Google Scholar
• Wong JW, Koo JY. Delusions of parasitosis. Indian J Dermatol. 2013;58(1):49–52. doi: 10.4103/0019-5154.105309.
   PubMedGoogle Scholar
• Reich A, Kwiatkowska D, Pacan P. Delusions of parasitosis: an update. Dermatol Ther. 2019;9(4):631–638. doi: 10.1007/s13555-019-00324-3.
   PubMed Web of Science ®Google Scholar
• Vahabzadeh M, Ghassemi Toussi A. Misdiagnosed pruritus; formication due to chronic amphetamine abuse. Asia Pac J Med Toxicol. 2016;5(1):32–34.
   Google Scholar
• Hinkle NC. Ekbom syndrome: the challenge of “invisible bug” infestations. Annu Rev Entomol. 2010;55:77–94. doi: 10.1146/annurev.ento.54.110807.090514.
   PubMed Web of Science ®Google Scholar
• Creamer D, Gossop M. Dermatoses induced by illicit drugs. Rook’s textbook of dermatology. 9th ed., Wiley-Blackwell, 2016. p. 1–5.
   Google Scholar
• Fink B, Landthaler M, Hafner C. Skin alterations due to illegal drug abuse. J Dtsch Dermatol Ges. 2011;9(8):633–638; quiz 639. doi: 10.1111/j.1610-0387.2011.07699.x.
   PubMed Web of Science ®Google Scholar
• Del Giudice P. Cutaneous complications of intravenous drug abuse. Br J Dermatol. 2004;150(1):1–10. doi: 10.1111/j.1365-2133.2004.05607.x.
   PubMed Web of Science ®Google Scholar
• Connolly JO, Gillmore JD, Lachmann HJ, et al. Renal amyloidosis in intravenous drug users. QJM. 2006;99(11):737–742. doi: 10.1093/qjmed/hcl092.
   PubMed Web of Science ®Google Scholar
• Lohr KM. Rheumatic manifestations of diseases associated with substance abuse. Semin Arthritis Rheum. 1987;17(2):90–111. doi: 10.1016/0049-0172(87)90032-1.
   PubMed Web of Science ®Google Scholar
• Lloyd-Smith E, Wood E, Zhang R, et al. Risk factors for developing a cutaneous injection-related infection among injection drug users: a cohort study. BMC Public Health. 2008;8(1):405. doi: 10.1186/1471-2458-8-405.
   PubMedGoogle Scholar
• Voron DA. Alopecia and amphetamine use. JAMA. 1988;260(2):183–184. doi: 10.1001/jama.1988.03410020043024.
   PubMed Web of Science ®Google Scholar
• Bilac O, Kütük M, Bilaç C. Hair loss due to methylphenidate use: a case study. Indian J Psychiatry. 2018;60(1):159–160. doi: 10.4103/psychiatry.IndianJPsychiatry_156_16.
   PubMed Web of Science ®Google Scholar
• Brahm NC, Hamilton DR. Alopecia following initiation of lisdexamfetamine in a pediatric patient. Prim Care Compan CNS Disord. 2009;11(6):23805.
   Google Scholar
• Chavez-Alvarez S, Villarreal-Alfaro-Lopez AL, Vazquez-Martinez O, et al. Diffuse alopecia areata associated with weight-loss pills. Int J Trichol. 2019;11(6):236–237. doi: 10.4103/ijt.ijt_101_19.
   PubMedGoogle Scholar
• Nappo SA, Tabach R, Noto AR, et al. Use of anorectic amphetamine-like drugs by Brazilian women. Eat Behav. 2002;3(2):153–165. doi: 10.1016/s1471-0153(01)00054-x.
   PubMedGoogle Scholar
• Malkud S. Telogen effluvium: a review. J Clin Diagn Res. 2015;9(9):WE01.
   PubMedGoogle Scholar
• Sinclair RD, Dawber RP. Androgenetic alopecia in men and women. Clin Dermatol. 2001;19(2):167–178. doi: 10.1016/s0738-081x(00)00128-0.
   PubMed Web of Science ®Google Scholar
• Hamalian G, Citrome L. Stimulant-induced trichotillomania. Subst Abus. 2010;31(1):68–70. doi: 10.1080/08897070903442723.
   PubMed Web of Science ®Google Scholar
• Narine C, Sarwar SR, Rais TB. Adderall-induced trichotillomania: a case report. Innov Clin Neurosci. 2013;10(7–8):13.
   PubMedGoogle Scholar
• Gunes S. Modified-release methylphenidate-related trichotillomania in a boy with autism spectrum disorder. J Child Adolesc Psychopharmacol. 2017;27(7):675–676. doi: 10.1089/cap.2017.0001.
   PubMed Web of Science ®Google Scholar
• Hamamoto DT, Rhodus NL. Methamphetamine abuse and dentistry. Oral Dis. 2009;15(1):27–37. doi: 10.1111/j.1601-0825.2008.01459.x.
   PubMed Web of Science ®Google Scholar
• Shaner JW. Caries associated with methamphetamine abuse. New York State Dent J. 2002;68(10):20.
   Google Scholar
• Brown RE, Morisky DE, Silverstein SJ. Meth mouth severity in response to drug-use patterns and dental access in methamphetamine users. J Calif Dent Assoc. 2013;41(6):421–428. doi: 10.1080/19424396.2013.12222319.
   PubMedGoogle Scholar
• Hadzic S, Dedic A, Gojkov-Vukelic M, et al. The effect of psychoactive substances (drugs) on the presence and frequency of oral Candida species and Candida dubliniensis. Mater Sociomed. 2013;25(4):223–225. doi: 10.5455/msm.2013.25.223-225.
   PubMedGoogle Scholar
• Brown PD, Ebright JR. Skin and soft tissue infections in injection drug users. Curr Infect Dis Rep. 2002;4(5):415–419. doi: 10.1007/s11908-002-0008-0.
   PubMedGoogle Scholar
• Binswanger IA, Kral AH, Bluthenthal RN, et al. High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clin Infect Dis. 2000;30(3):579–581. doi: 10.1086/313703.
   PubMed Web of Science ®Google Scholar
• Brett MM, Hood J, Brazier JS, et al. Soft tissue infections caused by spore-forming bacteria in injecting drug users in the United Kingdom. Epidemiol Infect. 2005;133(4):575–582. doi: 10.1017/s0950268805003845.
   PubMed Web of Science ®Google Scholar
• Chen JL, Fullerton KE, Flynn NM. Necrotizing fasciitis associated with injection drug use. Clin Infect Dis. 2001;33(1):6–15. doi: 10.1086/320874.
   PubMed Web of Science ®Google Scholar
• Money S, Garber B. Infections in the injection drug abuser. Curr Emerg Hosp Med Rep. 2018;6(4):157–161. doi: 10.1007/s40138-018-0169-2.
   Web of Science ®Google Scholar
• Elikowski W, Małek-Elikowska M, Lisiceka M, et al. Eikenella corrodens endocarditis of the tricuspid valve in an intravenous drug user. Pol Merkur Lek Organ Pol Tow Lek. 2017;42:81–83.
   PubMedGoogle Scholar
• Dorairaj JJ, Healy C, McMenamin M, et al. The untold truth about “bath salt” highs: a case series demonstrating local tissue injury. J Plast Reconstr Aesthet Surg. 2012;65(2):e37–e41. doi: 10.1016/j.bjps.2011.10.004.
   PubMed Web of Science ®Google Scholar
• Leen C, Brettle R. Fungal infections in drug users. J Antimicrob Chemother. 1991;28(Suppl. A):83–96. doi: 10.1093/jac/28.suppl_a.83.
   PubMedGoogle Scholar
• Meyerowitz EA, Sanchez S, Mansour MK, et al. Isolated cerebral mucormycosis in immunocompetent adults who inject drugs: case reports and systematic review of the literature. Open Forum Infect Dis. 2020;7(12):ofaa552. doi: 10.1093/ofid/ofaa552.
   PubMed Web of Science ®Google Scholar
• Karakus Y, Cak Esen T. Exfoliative skin reactions with methylphenidate and desensitization procedures in two cases. J Child Adolesc Psychopharmacol. 2019;29(3):247–248. doi: 10.1089/cap.2018.0081.
   PubMed Web of Science ®Google Scholar
• Ukoha UT, Pandya AG, Dominguez AR. Morbilliform drug eruptions. In: Cutaneous drug eruptions. Springer; 2015. p. 45–53.
   Google Scholar
• Coskun M, Tutkunkardas MD, Zoroglu S. OROS methylphenidate-induced skin eruptions. J Child Adolesc Psychopharmacol. 2009;19(5):593–594. doi: 10.1089/cap.2009.0009.
   PubMed Web of Science ®Google Scholar
• Confino-Cohen R, Goldberg A. Successful desensitization of methylphenidate-induced rash. J Child Adolesc Psychopharmacol. 2005;15(4):703–705. doi: 10.1089/cap.2005.15.703.
   PubMed Web of Science ®Google Scholar
• Goyal R, Arroyave A, Malik S. Urticaria and angioedema secondary to methylphenidate exposure in a young child. J Child Adolesc Psychopharmacol. 2015;25(9):731–733. doi: 10.1089/cap.2014.0040.
   PubMed Web of Science ®Google Scholar
• Deloach-Banta L. Lichenoid drug eruption: crystal methamphetamine or adulterants? Cutis. 1994;53(2):97–98.
   PubMed Web of Science ®Google Scholar
• Heinzerling LM, Pichler W, Anliker MD. Acute generalized exanthematous pustulosis induced by methylphenidate: a new adverse effect. Arch Dermatol. 2011;147(7):872–873. doi: 10.1001/archdermatol.2011.179.
   PubMedGoogle Scholar
• Roberts H, Chamberlain A, Rennick G, et al. Severe toxic epidermal necrolysis precipitated by amphetamine use. Australas J Dermatol. 2006;47(2):114–116. doi: 10.1111/j.1440-0960.2006.00243.x.
   PubMed Web of Science ®Google Scholar
• Wetzel M, Surkhabi W, Jung JY. Stevens-Johnson syndrome/toxic epidermal necrolysis associated with ecstasy exposure. Australas J Dermatol. 2020;61(3):276–277. doi: 10.1111/ajd.13265.
   PubMed Web of Science ®Google Scholar
• Gontijo B, Bittencourt FV, Lourenço LFS. Skin manifestations of illicit drug use. An Bras Dermatol. 2006;81(4):307–317. doi: 10.1590/S0365-05962006000400002.
   Google Scholar
• Wollina U, Kammler HJ, Hesselbarth N, et al. Ecstasy pimples – a new facial dermatosis. Dermatology. 1998;197(2):171–173. doi: 10.1159/000017992.
   PubMed Web of Science ®Google Scholar
• Rifkin S. Amphetamine-induced angiitis leading to renal failure. South Med J. 1977;70(1):108–109. doi: 10.1097/00007611-197701000-00050.
   PubMed Web of Science ®Google Scholar
• Woodburn K, Murie J. Vascular complications of injecting drug misuse. Br J Surg. 1996;83(10):1329–1334. doi: 10.1002/bjs.1800831005.
   PubMed Web of Science ®Google Scholar
• Pieper B, Kirsner RS, Templin TN, et al. Chronic venous disease and injection drug use. Arch Intern Med. 2007;167(16):1807–1807.
   PubMedGoogle Scholar
• Pieper B, Templin T. Chronic venous insufficiency in persons with a history of injection drug use. Res Nurs Health. 2001;24(5):423–432. doi: 10.1002/nur.1042.
   PubMed Web of Science ®Google Scholar
• Pieper B, Templin T. Lower extremity changes, pain, and function in injection drug users. J Subst Abuse Treat. 2003;25(2):91–97. doi: 10.1016/s0740-5472(03)00113-2.
   PubMed Web of Science ®Google Scholar
• Syed RH, Moore TL. Methylphenidate and dextroamphetamine-induced peripheral vasculopathy. J Clin Rheumatol. 2008;14(1):30–33. doi: 10.1097/RHU.0b013e3181639aaa.
   PubMed Web of Science ®Google Scholar
• Khouri C, Blaise S, Carpentier P, et al. Drug‐induced Raynaud’s phenomenon: beyond β‐adrenoceptor blockers. Br J Clin Pharmacol. 2016;82(1):6–16. doi: 10.1111/bcp.12912.
   PubMed Web of Science ®Google Scholar
• Tan B, Foley P. Guttate psoriasis following ecstasy ingestion. Australas J Dermatol. 2004;45(3):167–169. doi: 10.1111/j.1440-0960.2004.00080.x.
   PubMedGoogle Scholar
• Zink A, Herrmann M, Fischer T, et al. Addiction: an underestimated problem in psoriasis health care. J Eur Acad Dermatol Venereol. 2017;31(8):1308–1315. doi: 10.1111/jdv.14204.
   PubMed Web of Science ®Google Scholar
• Tomlinson I, Jayson M. Systemic sclerosis after therapy with appetite suppressants. J Rheumatol. 1984;11(2):254.
   PubMed Web of Science ®Google Scholar
• Silman AJ, Hochberg MC. Occupational and environmental influences on scleroderma. Rheum Dis Clin North Am. 1996;22(4):737–749. doi: 10.1016/s0889-857x(05)70298-2.
   PubMed Web of Science ®Google Scholar
• Aeschlimann A, De Truchis P, Kahn M. Scleroderma after therapy with appetite suppressants: report on four cases. Scand J Rheumatol. 1990;19(1):87–90. doi: 10.3109/03009749009092627.
   PubMed Web of Science ®Google Scholar
• Cole C, Jones L, McVeigh J, et al. Adulterants in illicit drugs: a review of empirical evidence. Drug Test Anal. 2011;3(2):89–96. doi: 10.1002/dta.220.
   PubMed Web of Science ®Google Scholar
• Sim MG, Khong E, Hulse G. Injecting drug use and skin lesions. Aust Fam Physician. 2004;33(7):519–522.
   PubMedGoogle Scholar
• Horowitz H. Learning to recognize scarring among intravenous drug users: a tool for HIV risk reduction. Am J Public Health. 1997;87(7):1233–1234. doi: 10.2105/ajph.87.7.1233.
   PubMed Web of Science ®Google Scholar
• Weidman A, Fellner M. Cutaneous manifestations of heroin and other addictive drugs. Study and analysis. N Y State J Med. 1971;71(22):2643–2646.
   PubMedGoogle Scholar
• Blumstein H, Roberts JR. Retained needle fragments and digital dissection. N Engl J Med. 1993;328(19):1426–1426. doi: 10.1056/NEJM199305133281916.
   PubMed Web of Science ®Google Scholar
• Moshiri M, Rahimi P, Etemad L. Hunting meth mites by a cigarette fire: a case study. Int J Med Toxicol Forensic Med. 2020;10(1):25478.
   Web of Science ®Google Scholar
• Ravipati P, Conti B, Chiesa E, et al. Dermatillomania: strategies for developing protective biomaterials/cloth. Pharmaceutics. 2021;13(3):341. doi: 10.3390/pharmaceutics13030341.
   PubMed Web of Science ®Google Scholar
• Frieden J. Skin manifestations may signal crystal meth use. Fam Prac News. 2006;36(2):47. doi: 10.1016/S0300-7073(06)72526-9.
   Google Scholar
• Yaffee HS. Cutaneous stigmas associated with methedrine (methamphetamine). Arch Dermatol. 1971;104(6):687. doi: 10.1001/archderm.1971.04000240111019.
   PubMedGoogle Scholar
• Shima N, Nitta A, Kamata T, et al. Incorporation of zolpidem and methoxyphenamine into white hair strands after single administrations: influence of hair pigmentation on drug incorporation. Forensic Sci Int. 2019;301:67–75. doi: 10.1016/j.forsciint.2019.05.013.
   PubMed Web of Science ®Google Scholar
• Dinh QQ, Sinclair R. Female pattern hair loss: current treatment concepts. Clin Interv Aging. 2007;2(2):189.
   PubMed Web of Science ®Google Scholar
• Neraud B, Dewailly D. Drug-induced hyperandrogenism, in androgen excess disorders in women. Heidelberg: Springer; 2006. p. 121–127.
   Google Scholar
• Sinclair R. Telogen effluvium. Alopecia. 2018;25:83.
   Google Scholar
• Small CB, Klein RS, Friedland GH, et al. Community-acquired opportunistic infections and defective cellular immunity in heterosexual drug abusers and homosexual men. Am J Med. 1983;74(3):433–441. doi: 10.1016/0002-9343(83)90970-1.
   PubMed Web of Science ®Google Scholar
• Gunson TH, Oliver GF. Osler’s nodes and Janeway lesions. Australas J Dermatol. 2007;48(4):251–255. doi: 10.1111/j.1440-0960.2007.00397.x.
   PubMed Web of Science ®Google Scholar
• See I, Gokhale RH, Geller A, et al. National public health burden estimates of endocarditis and skin and soft-tissue infections related to injection drug use: a review. J Infect Dis. 2020;222(Suppl. 5):S429–S436. doi: 10.1093/infdis/jiaa149.
   PubMedGoogle Scholar
• Lorson WC, Heidel RE, Shorman MA. Microbial epidemiology of infectious endocarditis in the intravenous drug abuse population: a retrospective study. Infect Dis Ther. 2019;8(1):113–118. doi: 10.1007/s40121-019-0232-7.
   PubMed Web of Science ®Google Scholar
• Schirren CA, Berghaus TM, Sackmann M. Thrombotic thrombocytopenic purpura after ecstasy-induced acute liver failure. Ann Intern Med. 1999;130(2):163. doi: 10.7326/0003-4819-130-2-199901190-00020.
   PubMed Web of Science ®Google Scholar
• Baggott M, Jerome L, Stuart R. 3,4-Methylenedioxymethamphetamine (MDMA): a review of the English-language scientific and medical literature; 2001. Available from: http://www.maps.org/research/mdma/protocol/litreview.html
   Google Scholar
• Milroy CM, Parai JL. The histopathology of drugs of abuse. Histopathology. 2011;59(4):579–593. doi: 10.1111/j.1365-2559.2010.03728.x.
   PubMed Web of Science ®Google Scholar
• Schreml S, Szeimies R-M, Vogt T, et al. Cutaneous amyloidoses and systemic amyloidoses with cutaneous involvement. Eur J Dermatol. 2010;20(2):152–160. doi: 10.1684/ejd.2010.0842.
   PubMed Web of Science ®Google Scholar
• Kaushik KS, Kapila K, Praharaj A. Shooting up: the interface of microbial infections and drug abuse. J Med Microbiol. 2011;60(Pt 4):408–422. doi: 10.1099/jmm.0.027540-0.
   PubMed Web of Science ®Google Scholar
• Stone M, Stone D, MacGregor HA. Anatomical distribution of soft tissue sepsis sites in intravenous drug misusers attending an accident and emergency department. Br J Addict. 1990;85(11):1495–1496. doi: 10.1111/j.1360-0443.1990.tb01634.x.
   PubMedGoogle Scholar
• Murphy EL, DeVita D, Liu H, et al. Risk factors for skin and soft-tissue abscesses among injection drug users: a case-control study. Clin Infect Dis. 2001;33(1):35–40. doi: 10.1086/320879.
   PubMed Web of Science ®Google Scholar
• Kanangat S, Postlethwaite A, Hasty K, et al. Induction of multiple matrix metalloproteinases in human dermal and synovial fibroblasts by Staphylococcus aureus: implications in the pathogenesis of septic arthritis and other soft tissue infections. Arthritis Res Ther. 2006;8(6):R176. doi: 10.1186/ar2086.
   PubMed Web of Science ®Google Scholar
• Mihu MR, Roman-Sosa J, Varshney AK, et al. Methamphetamine alters the antimicrobial efficacy of phagocytic cells during methicillin-resistant Staphylococcus aureus skin infection. mBio. 2015;6(6):e01622-15. doi: 10.1128/mBio.01622-15.
   PubMed Web of Science ®Google Scholar
• Wang JH, Kwon HJ, Jang YJ. Staphylococcus aureus increases cytokine and matrix metalloproteinase expression in nasal mucosae of patients with chronic rhinosinusitis and nasal polyps. Am J Rhinol Allergy. 2010;24(6):422–427. doi: 10.2500/ajra.2010.24.3509.
   PubMed Web of Science ®Google Scholar
• Gonzales y Tucker RD, Frazee B. View from the front lines: an emergency medicine perspective on clostridial infections in injection drug users. Anaerobe. 2014;30:108–115. doi: 10.1016/j.anaerobe.2014.09.005.
   PubMed Web of Science ®Google Scholar
• Kimura AC, Higa JI, Levin RM, et al. Outbreak of necrotizing fasciitis due to Clostridium sordellii among black-tar heroin users. Clin Infect Dis. 2004;38(9):e87–e91. doi: 10.1086/383471.
   PubMed Web of Science ®Google Scholar
• Williamson N, Archibald C, Vliet J. Unexplained deaths among injection drug users: a case of probable clostridium myonecrosis. CMAJ. 2001;165(5):609–611.
   PubMed Web of Science ®Google Scholar
• Headley AJ. Necrotizing soft tissue infections: a primary care review. Am Fam Phys. 2003;68(2):323–328.
   PubMed Web of Science ®Google Scholar
• Lehner P, Powell H. Gas gangrene. BMJ. 1991;303(6796):240–242. doi: 10.1136/bmj.303.6796.240.
   PubMedGoogle Scholar
• Jia Z-J, Yan S-y, Bao Y-P, et al. Sexual behavior differences between amphetamine-type stimulants users and heroin users. J Addict Med. 2013;7(6):422–427. doi: 10.1097/ADM.0b013e3182a952b2.
   PubMed Web of Science ®Google Scholar
• Recio C, Piqué E, Lluch J, et al. Foliculitis por Candida en usuarios de drogas por vía parenteral. Enferm Infecc Microbiol Clín. 2003;21(7):386–387. doi: 10.1016/S0213-005X(03)72969-3.
   PubMedGoogle Scholar
• Sverd J, Hurwic MJ, David O, et al. Hypersensitivity to methylphenidate and dextroamphetamine: a report of two cases. Pediatrics. 1977;59(1):115–117.
   PubMed Web of Science ®Google Scholar
• Abdollahi M, Karimpour H, Khalaj S. Review of drug‐induced skin reactions. J Pharm Pract Res. 2003;33(1):12–15. doi: 10.1002/jppr200333112.
   Google Scholar
• Shoar NS, Marwaha R, Molla M. Dextroamphetamine–amphetamine. StatPearls Publishing; 2021.
   Google Scholar
• White SR. Amphetamine toxicity. Semin Respir Crit Care Med. 2002;23(1):27–36. doi: 10.1055/s-2002-20586.
   PubMed Web of Science ®Google Scholar
• Connor TJ. Methylenedioxymethamphetamine (MDMA, ‘ecstasy’): a stressor on the immune system. Immunology. 2004;111(4):357–367. doi: 10.1111/j.0019-2805.2004.01847.x.
   PubMed Web of Science ®Google Scholar
• Freire-Garabal M, Balboa JL, Núñez MJ, et al. Effects of amphetamine on T-cell immune response in mice. Life Sci. 1991;49(16):PL107–PL112. doi: 10.1016/0024-3205(91)90570-2.
   PubMed Web of Science ®Google Scholar
• Núñez-Iglesias MJ, Castro-Bolaño C, Losada C, et al. Effects of amphetamine on cell mediated immune response in mice. Life Sci. 1996;58(2):PL 29–PL 33. doi: 10.1016/0024-3205(95)02272-4.
   PubMed Web of Science ®Google Scholar
• Boyle NT, Connor TJ. Methylenedioxymethamphetamine (‘ecstasy’)‐induced immunosuppression: a cause for concern? Br J Pharmacol. 2010;161(1):17–32. doi: 10.1111/j.1476-5381.2010.00899.x.
   PubMed Web of Science ®Google Scholar
• Chao C, Jacobson LP, Tashkin D, et al. Recreational amphetamine use and risk of HIV-related non-Hodgkin lymphoma. Cancer Causes Control. 2009;20(5):509–516. doi: 10.1007/s10552-008-9258-y.
   PubMed Web of Science ®Google Scholar
• Armenian HK, Hoover DR, Rubb S, et al. Risk factors for non-Hodgkin’s lymphomas in acquired immunodeficiency syndrome (AIDS). Am J Epidemiol. 1996;143(4):374–379. doi: 10.1093/oxfordjournals.aje.a008751.
   PubMed Web of Science ®Google Scholar
• Rosen J, Darwin E, Tuchayi SM, et al. Skin changes and manifestations associated with the treatment of obesity. J Am Acad Dermatol. 2019;81(5):1059–1069. doi: 10.1016/j.jaad.2018.10.081.
   PubMed Web of Science ®Google Scholar
• Darke S, Kaye S, McKetin R, et al. Major physical and psychological harms of methamphetamine use. Drug Alcohol Rev. 2008;27(3):253–262. doi: 10.1080/09595230801923702.
   PubMed Web of Science ®Google Scholar